Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

4.0K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD39 and PD-L1 co-expression may serve as potential indicators for evaluating the efficacy of neoadjuvant immunotherapy in esophageal squamous cell carcinoma.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same author

OTUD5-TIF1γ-SMAD3/4 positive feedback loop inhibits TGF-β-induced EMT and metastasis in NSCLC.

Cell death & disease·2026
Same author

First Transcontinental Single Port Robotic Thoracic Surgery.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Organoid-based two-step drug screening for rapid identification of chemotherapy-resistant oesophageal squamous cell carcinoma and alternative therapies.

Clinical and translational medicine·2025
Same author

BUB1b impairs chemotherapy sensitivity via resistance to ferroptosis in lung adenocarcinoma.

Cell death & disease·2024
Same author

Appropriateness and Comprehensiveness of Using ChatGPT for Perioperative Patient Education in Thoracic Surgery in Different Language Contexts: Survey Study.

Interactive journal of medical research·2023
Same journal

Response to Commentary: Memory B Cells in Major Depressive Disorder: Toward Mechanistic and Clinical Refinement.

Current medical science·2026
Same journal

Real-World Analysis of Organ Transplantation-Specific Agent Based on Large Language Model in Post-Transplant Self-Management During Off-Hours: A Mixed-Methods Study.

Current medical science·2026
Same journal

Memory B Cells in Major Depressive Disorder: Toward Mechanistic and Clinical Refinement.

Current medical science·2026
Same journal

Timing and Location are Keys: ERCP Success and Its Benefit in MPD Injury after Acute Pancreatitis.

Current medical science·2026
Same journal

Global Burden of Peptic Ulcer Disease (1990-2021) and Projections to 2050: A Comprehensive Analysis of Age, Sex, and Socioeconomic Disparities.

Current medical science·2026
Same journal

Bone Morphogenetic Proteins in Obesity Management: Therapeutic Potential and Challenges Beyond the Skeleton.

Current medical science·2026
See all related articles

Related Experiment Video

Updated: Sep 20, 2025

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

112.3K

FOXM1 Promotes Non-Small Cell Lung Cancer Progression by Increasing CHEK1 Expression.

Xiao-Ning Lu1,2,3, Jun Chen1,2, Guang Han4

  • 1Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Current Medical Science
|May 28, 2025
PubMed
Summary
This summary is machine-generated.

Checkpoint kinase 1 (CHEK1) promotes non-small cell lung cancer (NSCLC) growth and spread. Forkhead box protein M1 (FOXM1) upregulates CHEK1, suggesting both are potential NSCLC therapeutic targets.

Keywords:
Checkpoint kinase 1Forkhead box protein M1Non-small cell lung cancerTherapeutic targetsTranscriptional activation

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Related Experiment Videos

Last Updated: Sep 20, 2025

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

112.3K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Non-small cell lung cancer (NSCLC) is a major cause of cancer mortality.
  • Understanding the molecular mechanisms driving NSCLC progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of checkpoint kinase 1 (CHEK1) in NSCLC.
  • To explore the regulatory relationship between CHEK1 and forkhead box protein M1 (FOXM1) in NSCLC.

Main Methods:

  • Assessed NSCLC cell migration, invasion, and proliferation using Transwell and CCK-8 assays.
  • Analyzed epithelial-mesenchymal transition (EMT) markers via Western blotting.
  • Quantified CHEK1 and FOXM1 expression in NSCLC tissues using real-time quantitative PCR.
  • Validated CHEK1 knockdown effects on tumor growth in animal models.
  • Investigated FOXM1 binding to the CHEK1 promoter using dual-luciferase reporter and ChIP assays.

Main Results:

  • FOXM1 and CHEK1 were found to be upregulated in NSCLC tissues.
  • CHEK1 overexpression enhanced NSCLC cell proliferation, while knockdown inhibited proliferation, EMT, and tumor growth.
  • FOXM1 directly binds to the CHEK1 promoter, leading to increased CHEK1 expression.

Conclusions:

  • CHEK1 plays a significant role in promoting NSCLC proliferation and tumor growth.
  • FOXM1 directly regulates CHEK1 expression, highlighting a key molecular interaction in NSCLC.
  • Both CHEK1 and FOXM1 represent promising therapeutic targets for NSCLC treatment.